| 1 | KIR3DL1
|
| Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells.
|
| Qin H, Wang Z, Du W, Lee WH, Wu X, Riggs AD, Liu CP.
|
| Proc Natl Acad Sci U S A 108(5):2016-21. Epub 2011 Jan 18.
2011
|
| 2 | KIR3DL1
|
| The First Ig Domain of KIR3DL1 Contacts MHC Class I at a Secondary Site.
|
| Fu L, Hazes B, Burshtyn DN.
|
| J Immunol 187(4):1816-25. Epub 2011 Jul 11.
2011
|
| 3 | KIR3DL1
|
| Upregulation of KIR3DL1 gene expression in intestinal mucosa in active celiac disease.
|
| Fernandez-Jimenez N, Santín I, Irastorza I, Plaza-Izurieta L, Castellanos-Rubio A, Vitoria JC, Bilbao JR.
|
| Hum Immunol 72(8):617-20. Epub 2011 May 13.
2011
|
| 4 | KIR3DL1, KIR3DL2, KIR3DL3, KIR3DS1
|
| Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B.
|
| Vivian JP, Duncan RC, Berry R, O'Connor GM, Reid HH, Beddoe T, Gras S, Saunders PM, Olshina MA, Widjaja JM, Harpur CM, Lin J, Maloveste SM, Price DA, Lafont BA, McVicar DW, Clements CS, Brooks AG, Rossjohn J.
|
| Nature 479(7373):401-5. doi: 10.1038/nature10517.
2011
|
| 5 | KIR3DL1
|
| Contribution of functional KIR3DL1 to ankylosing spondylitis.
|
| Zvyagin IV, Mamedov IZ, Britanova OV, Staroverov DB, Nasonov EL, Bochkova AG, Chkalina AV, Kotlobay AA, Korostin DO, Rebrikov DV, Lukyanov S, Lebedev YB, Chudakov DM.
|
| Cell Mol Immunol 7(6):471-6. Epub 2010 Sep 6.
2010
|
| 6 | KIR3DL1
|
| Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells.
|
| Parsons MS, Zipperlen K, Gallant M, Grant M.
|
| J Leukoc Biol 88(5):905-12. Epub 2010 Jul 27.
2010
|
| 7 | KIR3DL1
|
| Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.
|
| Al Omar S, Middleton D, Marshall E, Porter D, Xinarianos G, Raji O, Field JK, Christmas SE.
|
| Hum Immunol 71(10):976-81. Epub 2010 Jun 30.
2010
|
| 8 | KIR3DL1
|
| Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
|
| Mousavi T, Poormoghim H, Moradi M, Tajik N, Shahsavar F, Asadifar B.
|
| Iran J Immunol 7(2):88-95.
2010
|
| 9 | KIR3DL1
|
| Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis.
|
| Harvey D, Pointon JJ, Sleator C, Meenagh A, Farrar C, Sun JY, Senitzer D, Middleton D, Brown MA, Wordsworth BP.
|
| Ann Rheum Dis 68(4):595-8. Epub 2008 Nov 19.
2009
|
| 10 | E2F1, KIR3DL1
|
| E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
|
| Gao XN, Yu L.
|
| Biochem Biophys Res Commun 370(3):399-403. Epub 2008 Mar 20. 2008
|
| 11 | KIR3DL1
|
| Alleles and intron polymorphism of KIR3DL1 shown by combination of allele group-specific primers and sequencing.
|
| Sun JY, Oki A, Senitzer D.
|
| Tissue Antigens 72(6):578-80. Epub 2008 Sep 29.
2008
|
| 12 | KIR3DL1, KIR3DS1
|
| Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
|
| O'Connor GM, Guinan KJ, Cunningham RT, Middleton D, Parham P, Gardiner CM.
|
| J Immunol 178(1):235-41. 2007
|
| 13 | KIR3DL1, KIR3DS1
|
| Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.
|
| Norman PJ, Abi-Rached L, Gendzekhadze K, Korbel D, Gleimer M, Rowley D, Bruno D, Carrington CV, Chandanayingyong D, Chang YH, Crespi C, Saruhan-Direskeneli G, Fraser PA, Hameed K, Kamkamidze G, Koram KA, Layrisse Z, Matamoros N, Mila J, Park MH, Pitchappan RM, Ramdath DD, Shiau MY, Stephens HA, Struik S, Verity DH, Vaughan RW, Tyan D, Davis RW, Riley EM, Ronaghi M, Parham P.
|
| Nat Genet 39(9):1092-9. Epub 2007 Aug 12. 2007
|
| 14 | KIR3DL1, KIR3DS1
|
| Multiple copies of KIR 3DL/S1 and KIR 2DL4 genes identified in a number of individuals.
|
| Williams F, Maxwell LD, Halfpenny IA, Meenagh A, Sleator C, Curran MD, Middleton D.
|
| Hum Immunol 64(7):729-32. 2003
|
| 15 | KIR3DL1, KIR2DL4
|
| Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters.
|
| Stewart CA, Van Bergen J, Trowsdale J.
|
| J Immunol 170(12):6073-81. 2003
|
| 16 | KIR3DL1
|
| Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism.
|
| Gardiner CM, Guethlein LA, Shilling HG, Pando M, Carr WH, Rajalingam R, Vilches C, Parham P.
|
| J Immunol 166(5):2992-3001. 2001
|
| 17 | KIR3DL1
|
| The natural killer cell receptor specific for HLA-A allotypes : a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
|
| Pende D, et al.
|
| J Exp Med 184 : 505-518. 1996
|
| 18 | KIR3DL1
|
| Alternatively spliced forms of human killer inhibitory receptors.
|
| Döhring C, Samaridis J, Colonna M.
|
| Immunogenetics 44(3):227-30. No abstract available.
1996
|
| 19 | KIR3DL1
|
| Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
|
| D'Andrea A, et al.
|
| J Immunol 155 : 2306-2310. 1995
|
| 20 | KIR2DL1, KIR2DL3, KIR3DL1, KIR3DL2
|
| Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.
|
| Colonna M, et al.
|
| Science 268 : 405-408. 1995
|
| 21 | KIR2DL3, KIR2DS2, KIR2DS3, KIR3DL1, KIR3DL2
|
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
|
| Wagtmann N, et al.
|
| Immunity 2 : 439-449. 1995
|